Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.
about
PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicityWhere does a Staphylococcus aureus vaccine stand?Molecular Epidemiology of Staphylococcus aureus in the General Population in Northeast Germany: Results of the Study of Health in Pomerania (SHIP-TREND-0)The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivoNovel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis.Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact.The T Cell Response to Staphylococcus aureusUpdate on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital.Immune proteomics of Staphylococcus aureus.Microarray-based identification of human antibodies against Staphylococcus aureus antigens.Enterotoxin Gene Cluster-Encoded SEI and SElN from Staphylococcus aureus Isolates are Crucial for the Induction of Human Blood Cell Proliferation and Pathogenicity in RabbitsPredictors of colonization with Staphylococcus species among patients scheduled for cardiac and orthopedic interventions at tertiary care hospitals in north-eastern Germany-a prevalence screening study.Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review.Humoral immune consequences of Staphylococcus aureus ST239-associated bacteremia.Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases.
P2860
Q26825729-6B572A1D-6E06-4C20-9BFD-C161D0CAE3EFQ26828726-51E1512C-D160-4467-809B-0A53C033FD60Q30392662-42A60D0A-A273-4AE4-94AC-E74E38B8C769Q30415990-A4ED63C5-C5A0-4D6A-85F9-3BB101774B90Q34298337-EEFED3DF-0FEC-4331-8893-9DAC798D2C12Q36001974-6DEBA9BB-1A3B-491E-A48A-1B6F18021985Q36018380-EE7507B2-7F57-4F17-9C8A-0B7E90D0D43CQ36735452-7D62373E-6D1E-40AA-AFB3-6996D6D515F2Q37235247-71EF5B47-C346-4856-8397-D9758FADAC0BQ37606190-07499342-B5DA-4598-968C-7A5A6C6B2706Q37895214-133C7954-9427-46A7-A68F-F54C1F0C9976Q41486894-5884463E-2801-4D95-BE91-E055500F754CQ42182419-7179CD74-9432-42C2-9788-3C75F1125737Q47261443-90E6A9D0-56CE-490F-A5EA-29EF648A6F6AQ47654030-AA6AC8F8-B488-49E1-B6F8-00E38868CF02Q48365132-58BF72B8-301C-4B59-8FE5-07BD6EB40C1AQ55515231-72C0E704-FA62-4B5C-AE5F-F344B4D7C791
P2860
Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Characterization of infecting ...... phylococcus aureus bacteremia.
@ast
Characterization of infecting ...... phylococcus aureus bacteremia.
@en
Characterization of infecting ...... phylococcus aureus bacteremia.
@nl
type
label
Characterization of infecting ...... phylococcus aureus bacteremia.
@ast
Characterization of infecting ...... phylococcus aureus bacteremia.
@en
Characterization of infecting ...... phylococcus aureus bacteremia.
@nl
prefLabel
Characterization of infecting ...... phylococcus aureus bacteremia.
@ast
Characterization of infecting ...... phylococcus aureus bacteremia.
@en
Characterization of infecting ...... phylococcus aureus bacteremia.
@nl
P2093
P2860
P356
P1476
Characterization of infecting ...... phylococcus aureus bacteremia.
@en
P2093
Asko Järvinen
Dorothee Grumann
Eeva Ruotsalainen
Julia Kolata
Pentti Kuusela
Silva Holtfreter
Vesa P Kontinen
P2860
P304
P356
10.1128/CVI.00329-10
P577
2011-01-19T00:00:00Z